Zobrazeno 1 - 10
of 64
pro vyhledávání: '"C. Breton-Callu"'
Autor:
C. Tunon de Lara, Marc Debled, V Bubien, P. Lagarde, Michel Longy, M. Fournier, E Barrouk-Simonet, Simone Mathoulin-Pélissier, J Leroux, T Esnaud, F Chassaigne, C. Breton-Callu, Gaëtan MacGrogan, H. Charitansky, A. Petit, N Quenel-Tueux, Nicolas Sevenet, Françoise Bonnet
Publikováno v:
Cancer Research. 79:P5-09
Introduction Neoadjuvant chemotherapy (NAC) is proposed for locally advanced breast cancer (LABC) to increase the breast conservative treatment (BCT). In France, mastectomy is the risk-reducing prophylactic surgical strategy only for pre-symptomatic
Autor:
P. Maingon, E. Blais, M. Antoine, N. Pourel, C. Breton-Callu, Mahmut Ozsahin, C. Lefebvre, I. Troussier, J. H. Bourhis, A. Aamarcha, A. Mampuya, M. Gérard, P. Lagarde, B. Pichon, G. Kantor
Publikováno v:
Cancer/Radiothérapie. 21:584-596
Radiation-induced lung disease (RILD) is common after radiation therapy and represents cornerstone toxicities after treatment of thoracic malignancies. From a review of literature, the objective of this article was to summarize clinical and non-clini
Autor:
Delfine Lafon, C. Tunon de Lara, C. Breton-Callu, Michel Longy, N Quenel-Tueux, A. Petit, P. Lagarde, Gaëtan MacGrogan, Marc Debled, Nicolas Sevenet, M. Fournier, Françoise Bonnet, E Rarouk-Simonet, V Bubien
Publikováno v:
Cancer Research. 77:P5-16
Introduction Neoadjuvant chemotherapy (NAC) is proposed in case of locally advanced breast cancer (LABC) to improve breast conservative treatment (BCT). In the case of germline BRCA mutated (gBRCAm) patients, risk-reducing prophylactic surgical strat
Publikováno v:
Cancer/Radiothérapie. 20:299-303
Resume Objectif de l’etude L’irradiation du sein apres tumorectomie est le standard pour le cancer du sein invasif. Des etudes randomisees montrent que la radiotherapie hypofractionnee est equivalente chez des patients selectionnes. Cette etude s
Autor:
Marc Debled, Hayssam Soueidan, L. Mauriac, Thomas Bachelot, Justine Rudewicz, Barbara Lortal, Pamela Rabbitts, Hervé Bonnefoi, Richard Iggo, Catherine Daly, Gaëtan MacGrogan, Henry M. Wood, N. Madranges, C. Breton-Callu, Christine Tunon de Lara, Macha Nikolski, N Quenel-Tueux, Audrey Gros, Marina Pulido, M. Fournier, Florence Dalenc
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2015, pp.bjc.2015.247. ⟨10.1038/bjc.2015.247⟩
British Journal of Cancer, Cancer Research UK, 2015, pp.bjc.2015.247. ⟨10.1038/bjc.2015.247⟩
International audience; BACKGROUND:The aim of this study was to assess the efficacy of neoadjuvant anastrozole and fulvestrant treatment of large operable or locally advanced hormone-receptor-positive breast cancer not eligible for initial breast-con
Autor:
Hervé Bonnefoi, Christine Tunon de Lara, Lionel Bourdarias, S. Ferron, Louis Mauriac, Gaëtan MacGrogan, Marc Debled, C. Breton-Callu, M. Fournier, G. Hurtevent
Publikováno v:
European Journal of Cancer. 51:697-704
Background While the addition of targeted therapy to neoadjuvant chemotherapy (NACT) dramatically increases the rate of pathological complete response in HER2-positive breast cancer, no reduction in the rate of mastectomy has been observed in randomi
Autor:
E, Blais, B, Pichon, A, Mampuya, M, Antoine, P, Lagarde, G, Kantor, C, Breton-Callu, C, Lefebvre, M, Gerard, A, Aamarcha, M, Ozsahin, J, Bourhis, P, Maingon, I, Troussier, N, Pourel
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 21(6-7)
Radiation-induced lung disease (RILD) is common after radiation therapy and represents cornerstone toxicities after treatment of thoracic malignancies. From a review of literature, the objective of this article was to summarize clinical and non-clini
Autor:
M. Antoine, B. Henriques de Figueiredo, A. Ducournau, A. Petit, Benjamin Dallaudière, C. Breton-Callu, P. Sargos, P. Lagarde
Publikováno v:
Cancer/Radiothérapie. 18:132-135
Resume L’osteogenese imparfaite est une maladie rare, anciennement appelee maladie de Lobstein ou maladie des os de verre. De severite variable, elle se caracterise par une fragilite et une faible masse osseuse a l’origine de fractures multiples.
Autor:
B Sigal, Marc Debled, Hervé Bonnefoi, Véronique Becette, C. Tunon de Lara, A. Kerbrat, J-Y Pierga, Simone Mathoulin-Pélissier, Sofia Rivera, Florence Lerebours, L. Venat-Bouvet, Thomas Bachelot, Marina Pulido, Emmanuelle Fourme, G. Mac Grogan, Florence Dalenc, C. Breton-Callu, Jérôme Lemonnier, N Quenel-Tueux, M.-A. Mouret-Reynier
Publikováno v:
Revue d'Épidémiologie et de Santé Publique. 66:S154-S155
Background Few data are available on survival of breast cancer (BC) patients (pts) treated with neoadjuvant endocrine therapy (NET). Understanding how tumor response to NET is related to relapse risk would help clinicians make decisions about additio